- Home
- PRTA vs BHRB Comparison
PRTA vs BHRB Comparison
Compare PRTA & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- BHRB
- Stock Information
- Founded
- PRTA 2012
- BHRB 1852
- Country
- PRTA Ireland
- BHRB United States
- Employees
- PRTA N/A
- BHRB N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- BHRB Major Banks
- Sector
- PRTA Health Care
- BHRB Finance
- Exchange
- PRTA Nasdaq
- BHRB Nasdaq
- Market Cap
- PRTA 809.8M
- BHRB 865.8M
- IPO Year
- PRTA N/A
- BHRB N/A
- Fundamental
- Price
- PRTA $9.20
- BHRB $50.01
- Analyst Decision
- PRTA Buy
- BHRB Strong Buy
- Analyst Count
- PRTA 9
- BHRB 2
- Target Price
- PRTA $54.57
- BHRB $76.00
- AVG Volume (30 Days)
- PRTA 572.3K
- BHRB 41.9K
- Earning Date
- PRTA 05-07-2025
- BHRB 04-25-2025
- Dividend Yield
- PRTA N/A
- BHRB 4.40%
- EPS Growth
- PRTA N/A
- BHRB N/A
- EPS
- PRTA N/A
- BHRB 2.82
- Revenue
- PRTA $135,157,000.00
- BHRB $233,028,000.00
- Revenue This Year
- PRTA N/A
- BHRB $51.18
- Revenue Next Year
- PRTA $131.71
- BHRB $4.49
- P/E Ratio
- PRTA N/A
- BHRB $17.73
- Revenue Growth
- PRTA 47.92
- BHRB 113.92
- 52 Week Low
- PRTA $9.10
- BHRB $46.00
- 52 Week High
- PRTA $25.42
- BHRB $75.32
- Technical
- Relative Strength Index (RSI)
- PRTA 26.58
- BHRB 34.95
- Support Level
- PRTA $9.30
- BHRB $47.57
- Resistance Level
- PRTA $10.45
- BHRB $50.97
- Average True Range (ATR)
- PRTA 0.81
- BHRB 2.25
- MACD
- PRTA -0.15
- BHRB -0.09
- Stochastic Oscillator
- PRTA 2.77
- BHRB 27.95
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.